Keith Vrbicky, MD
Obstetrics & Gynecology · Norfolk, NENPI 1477561660
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,214 of the $1,407 with a category attached, or 86.3%. 16 manufacturers reported payments, led by AbbVie at 32.4% of the total. Reporting peaked in 2019 at $603 and has fallen 86.6% since, to $81 in 2025.
Across 57 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$456
- Seqirus USA Inc$421
- Daiichi Sankyo Inc.$133
- Biohaven Pharmaceuticals, Inc.$61
- Minerva Surgical, Inc$56
- Pfizer$49
- plus $232 from 10 others
Across 1,478 payments — averaging $16,007 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$19.4M
- Pfizer$2.8M
- GSK$484K
- Seqirus USA Inc$435K
- Johnson & Johnson$129K
- Exeltis, USA Inc.$82K
- plus $346K from 10 others
What the payments were for
- Travel & lodging$16011%
- Food & beverage$1,21486%
- Gifts$332%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $456 |
| Seqirus USA Inc | 3 | $421 |
| Daiichi Sankyo Inc. | 9 | $133 |
| Biohaven Pharmaceuticals, Inc. | 3 | $61 |
| Minerva Surgical, Inc | 1 | $56 |
| Pfizer | 6 | $49 |
| Novo Nordisk | 3 | $43 |
| Biogen | 2 | $39 |
| Astellas Pharma US Inc | 2 | $34 |
| Mayne Pharma Commercial LLC | 3 | $21 |
| Channel Medsystems, Inc. | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Abbott | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,407 in reported general payments places this provider in the 65th percentile of 242 obstetrics & gynecology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 110 | $4,513 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 12 | $3,376 |
| Levothyroxine Sodium | 168 | $1,454 |
| Estradiol | 30 | $911 |
| Estradiol (Once Weekly)Estradiol | 15 | $872 |
| Risedronate Sodium | 12 | $611 |
| Liothyronine Sodium | 17 | $540 |
| Pravastatin Sodium | 12 | $532 |
| Oxybutynin Chloride ErOxybutynin Chloride | 24 | $461 |
| Rosuvastatin Calcium | 31 | $449 |
| Simvastatin | 42 | $431 |
| Losartan Potassium | 38 | $367 |
| Cyproheptadine Hcl | 20 | $331 |
| Omeprazole | 17 | $291 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $290 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Norfolk
- John CoteOmaha$236K
- Gregory HeidrickLincoln$80K
- Robin ClemmerOmaha$19K
- Angela GroneBeatrice$17K
- Chandra LjunggrenLincoln$13K
- Emily NeriLincoln$13K
- Alicia MuhleisenLincoln$11K
- Michael BiancoNorth Platte$9K
- Deann PaulsonBeatrice$9K
- Todd MartinLincoln$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.